Bevacizumab, irinotecan, and radiotherapy versus standard temozolomide and radiotherapy in newly diagnosed, MGMT-non-methylated glioblastoma patients: First results from the randomized multicenter GLARIUS trial

Abstract only LBA2000 The full, final text of this abstract will be available at abstract.asco.org at 7:30 AM (EDT) on Saturday, June, 1, 2013, and in the Annual Meeting Proceedings online supplement to the June 20, 2013, issue of Journal of Clinical Oncology. Onsite at the Meeting, this abstract wi...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 31; no. 15_suppl; p. LBA2000
Main Authors Herrlinger, Ulrich, Schaefer, Niklas, Steinbach, Joachim Peter, Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Friedrich, Franziska, Stockhammer, Florian, Ringel, Florian, Braun, Christian, Kohnen, Ralf, Leutgeb, Barbara, Belka, Claus, Urbach, Horst, Stummer, Walter, Glas, Martin
Format Journal Article
LanguageEnglish
Japanese
Published 20.05.2013
Online AccessGet full text

Cover

More Information
Summary:Abstract only LBA2000 The full, final text of this abstract will be available at abstract.asco.org at 7:30 AM (EDT) on Saturday, June, 1, 2013, and in the Annual Meeting Proceedings online supplement to the June 20, 2013, issue of Journal of Clinical Oncology. Onsite at the Meeting, this abstract will be printed in the Saturday edition of ASCO Daily News.
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2013.31.15_suppl.lba2000